Hyaline membrane disease of newborn. Respiratory distress syndrome of newborn
Conditions
Interventions
Infantswith wieght less than 1500 grams with only disease HMD without other disease for example congenital heart disease,asphyxia , chromosomal abnormalities, renal-electrolyte, diaphragmatic hernia
Treatment - Drugs
Sponsors
North Khorasan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The criteria for entrance study infants less than 37 weeks with HMD The criteria for exit of study infant with other than disease associated with HMD for example HIE and CHD ....
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effect of fluticasone inhaler in decrease severity HMD. Timepoint: at birth time and starting treatment to discharge at hospital. Method of measurement: duration hospitalizatin and mechanical ventilation. | — |
Secondary
| Measure | Time frame |
|---|---|
| There is no side effect with use fluticasone inhaler. Timepoint: at birth time and starting treatment to discharge at hosp. Method of measurement: duration hospitalizatin and mechanical ventilation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Ghasem Bayani
North Khorasan University of Medical Sciences
Outcome results
None listed